The development of Next Generation Sequencing (NGS) has revolutionized the diagnostic
approach of mitochondrial disorders, particularly in children. The purpose of our project is
to develop a NGS strategy to identify the genetic defect in 250 patients, to confirm the clinical
diagnosis of the disease.
